Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.50
+0.16004.79%
Post-market: 3.500.00000.00%19:59 EDT
Volume:22.90M
Turnover:80.71M
Market Cap:1.87B
PE:-3.42
High:3.63
Open:3.39
Low:3.37
Close:3.34
52wk High:7.18
52wk Low:2.77
Shares:535.00M
Float Shares:522.33M
Volume Ratio:1.28
T/O Rate:4.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0219
EPS(LYR):-1.4410
ROE:-56.58%
ROA:-27.33%
PB:2.05
PE(LYR):-2.43

Loading ...

Feb 25, 2026

Major Issues Report

Form 8-K - Current report
Feb 19, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Director Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $138,400
Feb 18, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Taylor Ben R proposes to sell 13426 shares, with a total value of approximately $41352.08.
Feb 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 20, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Director Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $178,800
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 06, 2026

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS' Director B. Borgeson proposes to sell 220,000 shares, with a total value of approximately $959.2K.
Jan 05, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Director Gibson Christopher proposes to sell 40,000 Shares, with a total value of approximately $170,000.
Dec 29, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Taylor Ben R proposes to sell 21,383 shares, with a total value of approximately $89K.
Dec 22, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Najat Khan proposes to sell 124,403 Shares, with a total value of approximately $548,587.96
Dec 19, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals's Officer Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $180,000.
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 04, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $185,200.
Dec 02, 2025

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS Director Blake Borgeson proposes to sell 220,000 shares, with a total value of approximately $961,400
Nov 26, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2025

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS' Director and Officer Gibson proposes to sell 40000 shares, with a total value of approximately $166,400.
Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2025

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Christopher Gibson proposes to sell 40,000 Shares, with a total value of approximately $208,400.